We are in the process of evaluating additional cell lines, including the HCT116 colon carcinoma line and its p53 knockout and p21 knockout derivatives, after treatment with moderate concentrations of cisplatin, oxaliplatin, and paclitaxel. Here, TP53 is linked to colon carcinoma.